BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395 | +6.2% | 130,097 | +15.0% | 0.00% | +33.3% |
| Q2 2023 | $372 | -85.2% | 113,093 | -68.8% | 0.00% | -91.4% |
| Q4 2022 | $2,508 | -99.9% | 362,544 | -54.6% | 0.04% | -2.8% |
| Q2 2022 | $3,303,000 | +486.7% | 798,048 | +4170.6% | 0.04% | +500.0% |
| Q1 2021 | $563,000 | +17.8% | 18,687 | +396.3% | 0.01% | -80.0% |
| Q2 2019 | $478,000 | +46.2% | 3,765 | +81.0% | 0.03% | -41.2% |
| Q1 2019 | $327,000 | – | 2,080 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |